TABLE 2.
Medications | 6 mo | 12 mo | 24 mo | 36 mo | 48 mo | End of therapy | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
No. | Mean weight loss, kg | No. | Mean weight loss, kg | No. | Mean weight loss, kg | No. | Mean weight loss, kg | No. | Mean weight loss, kg | No. | Mean weight loss, kg | |
Alla | 93 | −8.5 | 74 | −11.2 | 36 | −12.7 | 19 | −16.5 | 7 | −6.1 | 78 | −10.6 |
| ||||||||||||
Liraglutide | 57 | −8.1 | 46 | −10.7 | 21 | −8.6 | 12 | −7.7 | 3 | −16.7 | 46 | −10.2 |
| ||||||||||||
Phentermine/topiramate | 29 | −8.0 | 20 | −12.0 | 12 | −11.5 | 5 | −19.1 | 1 | −4.8 | 25 | −11.0 |
Includes results for patients taking phentermine/topiramate, liraglutide, phentermine, naltrexone/bupropion, and orlistat.